Despite the volatility, several modalities demonstrated strong growth between 2014 and 2016.

Here’s a look at the top 3, all of which offer some interesting opportunities in key areas.

Download the complete report for more information.

Go Further

While our report offers a strong handle on these growth areas, it won’t let you know equipment counts for specific hospitals so you can see which ones offer the best sales opportunities. For that, you need the deep granular detail available in our hospital database, which lets you see equipment counts for nearly 70% of Argentina’s hospitals, key contacts for purchase and much more. Contact us to subscribe to our database so you can get started today on uncovering new sales from the Argentine hospital market.

Beyond that, we can also help with fresh data on market share so you can see where you stand in comparison to your competitors or deliver some custom research to further help you edge out the competition with crucial market intelligence.

Vascular stents include coronary, peripheral, carotid, femoral and aortic aneurysm stents. Major driver for this market is the increasing disease burden coupled with increasing demand for minimally invasive procedures. Other factors driving growth include technological advancements in stents, increasing geriatric population and disease awareness.

However, indirect competition from alternative treatment procedures, stringent regulations, product failure/recall, etc. are some of the aspects restraining the market growth. Of the three types of stents in the market i.e. bare-metal stents (BMS), drug-eluting stents (DES), and bioabsorbable stents, DES accounted for the largest share in 2016. This can be primarily attributed to the lower risk of restenosis with DES over BMS.

The balloon-expandable stents segment is anticipated to growth at higher CAGR than the self-expanding stents due to their increasing use in angioplasty procedures. North America has the largest market share for vascular stents in 2016. However, the factors such as large population base, rising technology adoption and low manufacturing costs are expected to drive the Asian market with highest growth during the forecast period.

The vascular market is highly fragmented with key players including Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biotronik, B. Braun, Terumo Corporation, Stentys, MicroPort Scientific Corporation, Meril Life Sciences, Vascular Concepts, W. L. Gore and Associates, C. R. Bard (BD acquired), Endologix, Lombard Medical Technologies, Translumina and Jotec.